Blinatumomab: An FDA approved drug
Anjuimport25 May, 2022Health
The FDA approved the drug Blinatumomab in 2014 to treat patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that binds to CD19 (expressed on cells of B-lineage origin) and CD3 (expressed on T cells).
Related Bookmarks
- The Best Fitness Gym In Dubai- Enhance Fitness
- Cardiac Stress Test - Access Health Care Physicians, LLC
- Experienced and Certified Personal Trainer Bella Vista
- Is it Better to Color My Hair During a Keratin Treatment?
- Best IUI Centre in Faridabad| Asha IVF & Fertility Centre
- Lenalidomide: An off-white to pale-yellow solid powder
- Moisturizer for Sensitive Skin
- Composite Veneers Before And After
- Orthodontist in Burbank
- Sleep Apnea Treatment | Sleep Center Arlington, WA | Sleep Advantage
Recent Profiles
777sh
Dr. Pankaj Chaturvedi
Go88
Pain And Performance Medical Weightloss & Aestheti
Martech Properties
Skin Tree Aesthetics
Recoverycardubai
Spectrum Pharmatech Consultants
Taixiu79com
Amer Welding Solutions